Ravi K Goyal

15PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical genetics (excl. cancer genetics)Respiratory diseasesMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 27, 2025
Overall Survival With Palbociclib and Aromatase Inhibitor Versus Aromatase Inhibitor Alone in Older Patients With HR+/HER2- Metastatic Breast Cancer.

Adam M Brufsky, Rickard Sandin, Stella Stergiopoulos

|Aug 14, 2024
Treatment characteristics and outcomes in lower-risk, non-del(5q) myelodysplastic syndromes: findings from a medical record review in the USA, Canada and Europe.

Maria Diez-Campelo, Aylin Yucel, Ravi K Goyal

|Aug 01, 2024
Exploring the Association Between Heart Rate Control and Rehospitalization: A Real-World Analysis of Patients Hospitalized with Heart Failure with Reduced Ejection Fraction.

Freny Vaghaiwalla Mody, Ravi K Goyal, Mayank Ajmera

|Jun 27, 2024
Social Determinants of Health and Other Predictors in Initiation of Treatment with CDK4/6 Inhibitors for HR+/HER2- Metastatic Breast Cancer.

Ravi K Goyal, Sean D Candrilli, Susan Abughosh

|Apr 17, 2024
Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world study.

Muhammad Furqan, Siddharth Karanth, Ravi K Goyal

|Feb 04, 2024
Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic breast cancer.

Ravi K Goyal, Jingchuan Zhang, Keith L Davis

Pageof 3

Frequent Collaborators

2 joint publications

Beilei Cai

2 joint publications

Keith L Davis

1 joint publications

Shaum M Kabadi

1 joint publications

Michael Wang